Cargando…
Hypertrophic Cardiomyopathy in Infants from the Perspective of Cardiomyocyte Maturation
Hypertrophic cardiomyopathy (HCM) is characterized by ventricular wall hypertrophy with diastolic dysfunction. Pediatric HCM is distinguished from the adult in many aspects. Most children with HCM do not present clinically until the adolescent period, even when they are born with genetic mutations....
Autores principales: | Seok, Heeyoung, Oh, Jin-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424452/ https://www.ncbi.nlm.nih.gov/pubmed/34327880 http://dx.doi.org/10.4070/kcj.2021.0153 |
Ejemplares similares
-
Major Clinical Issues in Hypertrophic Cardiomyopathy
por: Lee, Hyun-Jung, et al.
Publicado: (2022) -
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023) -
Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
por: Kim, Kyung-Hee, et al.
Publicado: (2021) -
Functional maturation of nasal mucosa: role of secretory immunoglobulin A (SIgA)
por: Bellussi, Luisa, et al.
Publicado: (2013) -
Restrictive cardiomyopathy: definition and diagnosis
por: Rapezzi, Claudio, et al.
Publicado: (2022)